Mayra Ianhez (M Ianhez)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 21

Top Venues

Inflammation research : official journal of the European Histamine Research Society ... [et al.]

International journal of dermatology

Anais da Academia Brasileira de Ciencias

Journal of the European Academy of Dermatology and Venereology : JEADV

Universidade Federal de Goiás Faculdade de Medicina

Universidade Federal de Sao Paulo Escola Paulista de Medicina (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade Federal de Goiás Faculdade de Medicina

Brazil

Assistant Professor :: Department of Dermatology and Infectious Diseases

Education History

Universidade Federal de Sao Paulo Escola Paulista de Medicina

Brazil

PHD :: Department of Dermatology

Publications

Paulo Ricardo Criado, Hélio Amarante Miot, Mayra Ianhez
Eosinophilia and elevated IgE serum levels: a red flag: when your diagnosis is not a common atopic eczema or common allergy. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 72 (3) (2023)
Carolina Talhari, Paulo Ricardo Criado, Caio César Silva de Castro, Mayra Ianhez, Paulo Muller Ramos, Hélio Amarante Miot
Prevalence of and risk factors for post-COVID: Results from a survey of 6,958 patients from Brazil. Anais da Academia Brasileira de Ciencias 95 (1) (2023)
Paulo Ricardo Criado, Hélio Amarante Miot, Mayra Ianhez
Eosinophilia and elevated IgE serum levels: a red flag: when your diagnosis is not a common atopic eczema or common allergy. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 72 (3) (2023)
Paulo Ricardo Criado, Hélio Amarante Miot, Mayra Ianhez
Eosinophilia and elevated IgE serum levels: a red flag: when your diagnosis is not a common atopic eczema or common allergy. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 72 (3) (2023)
Paulo Ricardo Criado, Hélio Amarante Miot, Mayra Ianhez
Eosinophilia and elevated IgE serum levels: a red flag: when your diagnosis is not a common atopic eczema or common allergy. Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2023)
Carolina Talhari, Paulo Ricardo Criado, Caio César Silva de Castro, Mayra Ianhez, Paulo Muller Ramos, Hélio Amarante Miot
Prevalence of and risk factors for post-COVID: Results from a survey of 6,958 patients from Brazil. Anais da Academia Brasileira de Ciencias 95 (1) (2023)
Paulo Ricardo Criado, Daniel Lorenzini, Hélio Amarante Miot, Roberto Bueno Filho, Francisca Regina Oliveira Carneiro, Mayra Ianhez
New small molecules in dermatology: for the autoimmunity, inflammation and beyond. Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2023)
Mayra Ianhez, Allana Rodrigues César Araújo Luz, Eliandre Costa Palermo, Hélio Amante Miot
Dermal Filler Injections in Patients with Autoimmune and Immune-Mediated Diseases: A Survey with Dermatologists. Aesthetic plastic surgery (2023)
Mayra Rabelo Dos Santos, Mayra Ianhez, Bruno Nazeozeno Ribeiro, Boaventura Braz de Queiroz, Hélio Amarante Miot
Refractory pyoderma gangrenosum associated with rheumatoid arthritis successfully treated with upadacitinib. Comments on: "JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum". International journal of dermatology (2023)
Carolina Talhari, Paulo Ricardo Criado, Caio César Silva de Castro, Mayra Ianhez, Paulo Muller Ramos, Hélio Amarante Miot
Prevalence of and risk factors for post-COVID: Results from a survey of 6,958 patients from Brazil. Anais da Academia Brasileira de Ciencias 95 (1) (2023)
Luiz M C Almeida, Mayra Ianhez, Taciana Dal'Forno, Fabíola R Picosse, Flávia Ravelli, Christhine Kamamoto, Priscilla Sarlos, Linda F S Gold
Long-term maintenance treatment of rosacea: experts' opinion. International journal of dermatology (2023)
Paulo Muller Ramos, Mayra Ianhez, Caio César Silva de Castro, Carolina Talhari, Paulo Ricardo Criado, Hélio Amarante Miot
Post-COVID-19 hair loss: prevalence and associated factors among 5,891 patients. International journal of dermatology 61 (5) (2022)
Paulo Ricardo Criado, Mayra Ianhez, Paula Stéfany Rocha, Hélio Amarante Miot
Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (7) (2022)
Mayra Ianhez, Gabriel Peres, Hélio Amante Miot
Neutralizing Antibodies to Botulinum Toxin Type A Are Rare Following Aesthetic Indications. Aesthetic surgery journal 41 (11) (2021)
Gabriel Peres, Mayra Ianhez, Tatiana Cristina Figueira Polo, Luciana Patricia Fernandes Abbade, Hélio Amarante Miot
Concerning the heterogeneity of the studies included in meta-analyses. Comment on: "Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis". International journal of dermatology (2021)
Mayra Ianhez, Paulo Muller Ramos, Andy Goren, Hélio Amarante Miot
Androgen sensitivity in COVID-19 and antiandrogens: Prospective data are still needed. Dermatologic therapy 33 (6) (2020)
Hélio Amarante Miot, Mayra Ianhez, Paulo Muller Ramos
Self-reported cutaneous manifestations in 1429 Brazilian COVID-19-infected patients. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (3) (2020)
Paulo Muller Ramos, Mayra Ianhez, Hélio Amarante Miot
Alopecia and grey hair are associated with COVID-19 Severity. Experimental dermatology 29 (12) (2020)
Marilia Formentini Scotton Jorge, Ticiane Dionízio de Sousa Matos, Camila Fernandes Pollo, Bianca Sakamoto Ribeiro Paiva, Mayra Ianhez, Juliana Catucci Boza, Silmara Meneguin, Juliano Villaverde Schmitt, Daniel Holthausen Nunes, Joel C Lastoria, Hélio Amarante Miot
Dimensionality and psychometric analysis of DLQI in a Brazilian population. Health and quality of life outcomes 18 (1) (2020)
Mayra Ianhez, Sebastião A Pinto, Ediléia Bagatin, Hélio Amarante Miot
Response to the correspondence: a randomized, open, controlled trial of tretinoin 0.05% cream vs. low-dose oral isotretinoin for the treatment of field cancerization. International journal of dermatology 58 (10) (2019)
Mayra Ianhez
Skin field cancerization - an in vivo model to prevent nonmelanoma skin cancer: expanding the alternatives for treatment. The British journal of dermatology 179 (5) (2019)

Mayra Ianhez.css-eqlu8i{font-size:small;padding-left:4px;} (M Ianhez)

Publication Activity (10 Years)

Top Topics

Top Venues

Mayra Ianhez (M Ianhez)